Skip to main content
Livermore
Livermore
ZHEN

First Light Asset Management, LLC

SEC CIK
0001600004
Latest filing
Aug 14, 2026

Holdings in Q2 2025

Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.

Institution overview
Positions
38
+1 vs. Q1 2025
Portfolio value
$771.3M
−$104.4M (−11.9%) vs. Q1 2025
Filed
Aug 14, 2025
SEC
Holdings of First Light Asset Management, LLC in Q2 2025
SecurityClassSharesValue% of portfolioShare changeActionHistory
ANABAnaptysbio, IncCOM3,539,593$78.6M10.2%−1,094,009−23.6%ReducedHistory
CNTACentessa Pharmaceuticals plcSPONSORED ADS4,293,411$56.4M7.3%−580,713−11.9%ReducedHistory
PHLTPerformant Healthcare IncCOM13,170,381$52.7M6.8%+1,477,348+12.6%AddedHistory
NEONeogenomics IncCOM NEW6,846,432$50.0M6.5%+803,610+13.3%AddedHistory
AXGNAxogen, Inc.COM4,529,243$49.1M6.4%+55,028+1.2%AddedHistory
HCATHealth Catalyst, Inc.COM12,230,181$46.1M6.0%+1,793,374+17.2%AddedHistory
TWSTTwist Bioscience CorpCOM945,033$34.8M4.5%−273,666−22.5%ReducedHistory
ATRCAtriCure, Inc.COM1,015,170$33.3M4.3%−299,548−22.8%ReducedHistory
SIBNSI-BONE, Inc.COM1,751,001$33.0M4.3%+138,593+8.6%AddedHistory
IRTCiRhythm Holdings, Inc.COM187,355$28.8M3.7%−137,691−42.4%ReducedHistory
CRNXCrinetics Pharmaceuticals, Inc.COM864,136$24.9M3.2%+8,717+1.0%AddedHistory
ORGOOrganogenesis Holdings Inc.COM6,777,163$24.8M3.2%+6,777,163NewHistory
EWTXEdgewise Therapeutics, Inc.COM1,714,019$22.5M2.9%−138,271−7.5%ReducedHistory
RAREUltragenyx Pharmaceutical Inc.COM547,905$19.9M2.6%−84,128−13.3%ReducedHistory
ESTAEstablishment Labs Holdings Inc.COM417,157$17.8M2.3%+80,287+23.8%AddedHistory
ADMAAdma Biologics, Inc.COM952,096$17.3M2.2%+952,096NewHistory
SENSSenseonics Holdings, Inc.COM35,708,124$17.0M2.2%+31,050,619+666.7%AddedHistory
KRMDKORU Medical Systems, Inc.COM4,681,626$16.8M2.2%+226,700+5.1%AddedHistory
NPCENeuroPace IncCOM1,380,410$15.4M2.0%−203,638−12.9%ReducedHistory
VERAVera Therapeutics, Inc.CL A562,981$13.3M1.7%−612,898−52.1%ReducedHistory
MDXGMimedx Group, Inc.COM1,927,494$11.8M1.5%−1,525,580−44.2%ReducedHistory
CAICaris Life Sciences, Inc.COM443,043$11.2M1.5%+443,043NewHistory
BFLYButterfly Network, Inc.COM CL A5,465,032$10.9M1.4%−40,617−0.7%ReducedHistory
CDTXCidara Therapeutics, Inc.COM NEW180,615$8.80M1.1%+180,615NewHistory
EVHEvolent Health, Inc.CL A738,550$8.32M1.1%+153,114+26.2%AddedHistory
MASS908 Devices Inc.COM1,067,613$7.61M1.0%−633,482−37.2%ReducedHistory
ELDNEledon Pharmaceuticals, Inc.COM2,600,498$7.05M0.9%+271,730+11.7%AddedHistory
GHGuardant Health, Inc.COM128,868$6.71M0.9%−142,247−52.5%ReducedHistory
INSMINSMED IncCOM PAR $.0162,901$6.33M0.8%−5,252−7.7%ReducedHistory
SLPSimulations Plus, Inc.COM357,157$6.23M0.8%+357,157NewHistory
XENEXenon Pharmaceuticals Inc.COM188,367$5.90M0.8%−439,537−70.0%ReducedHistory
RGENRepligen CorpCOM43,949$5.47M0.7%−43,901−50.0%ReducedHistory
ALHCAlignment Healthcare, Inc.COM383,663$5.37M0.7%−572,778−59.9%ReducedHistory
EOLSEvolus, Inc.COM520,631$4.80M0.6%+520,631NewHistory
RDNTRadNet, Inc.COM68,694$3.91M0.5%+68,694NewHistory
JANXJanux Therapeutics, Inc.COM149,596$3.46M0.4%−509,228−77.3%ReducedHistory
GPCRStructure Therapeutics Inc.SPONSORED ADS122,226$2.53M0.3%−10,154−7.7%ReducedHistory
LNTHLantheus Holdings, Inc.Stock30,045$2.46M0.3%+30,045NewHistory

Sold out since Q1 2025 (7)

Positions held at the end of Q1 2025 that are gone from this filing.

Positions of First Light Asset Management, LLC sold out since Q1 2025
SecurityClassShares in Q1 2025Value in Q1 2025% of portfolio in Q1 2025History
TMDXTransMedics Group, Inc.COM107,860$7.26M0.8%History
OSCROscar Health, Inc.CL A522,302$6.85M0.8%History
FNAParagon 28, Inc.COM500,000$6.53M0.7%History
TNDMTandem Diabetes Care IncCOM NEW245,257$4.70M0.5%History
PODDInsulet CorpStock17,022$4.47M0.5%History
PCVXVaxcyte, Inc.COM94,420$3.57M0.4%History
Direxion Daily S&P Biotech Bear 3X Shares25490K745Common Stocks140,282$2.30M0.3%–